Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) 90 count (NDC 43598-742-90) and b) 1000 count (NDC 43598-742-10) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA, , packaged in bottles.
Published November 10, 2021 · Recall initiated: October 5, 2021
Summary
FDA records drug Class II recall D-0081-2022, published November 10, 2021 and initiated October 5, 2021. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: a) 776 bottles, b) 84 bottles; Lot: a) L100256, exp 01/2023; b) L100257, exp 01/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
What to do
Voluntary: Firm initiated · Letter
Get an email if EZETIMIBE AND SIMVASTATIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- EZETIMIBE AND SIMVASTATIN
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Nationwide in the US
- UPC
- 0343598745909
- Lot
- a) L100256, exp 01/2023; b) L100257, exp 01/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEzetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: GlenmarkJune 18, 2025
- FDAEzetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr.November 17, 2021
- FDAEzetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy'sNovember 17, 2021
- FDADr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr.November 10, 2021
- FDADr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) 30 count (NDC 43598-745-30), b) 90 count (NDCNovember 10, 2021
- FDAASC PneumoLiner device, Part No. WA90500US (US market only) The Pneumoliner device is intended for use as aNovember 3, 2021
Questions about this recall
Was Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) 90 count (NDC 43598-742-90) and b) 1000 count (NDC 43598-742-10) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA, , packaged in bottles. recalled?
Yes. FDA published recall D-0081-2022 on November 10, 2021. Reported hazard: Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: EZETIMIBE AND SIMVASTATIN. UPC: 0343598745909.